Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study

被引：0

作者：

Bipin Sethi

Khalid Al-Rubeaan

Mustafa Unubol

Maria A. Mabunay

Baptiste Berthou

Valerie Pilorget

Shireene R. Vethakkan

Gustavo Frechtel

机构：

[1] Care Hospital,Faculty of Medicine

[2] Research and Scientific Center Sultan Bin Abdulaziz Humanitarian City,Hospital de Clínicas

[3] Aydın Adnan Menderes University,undefined

[4] IT&M Stats for Sanofi,undefined

[5] Sanofi,undefined

[6] University Malaya Medical Centre,undefined

[7] Universidad de Buenos Aires,undefined

来源：

Diabetes Therapy | 2022年 / 13卷

关键词：

Basal insulin; Glycaemic control; Hypoglycaemia; Insulin glargine 300 U/mL; Type 2 diabetes mellitus;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1395 / 1408

页数：13

共 50 条

[21] REAL-WORLD EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES (T2DM): THE ATOS STUDY
Galstyan, G.
Tirosh, A.
Vargas-Uricoechea, H.
Mabunay, M.
Quan, J.
Pilorget, V.
Cherkasov, D.
Naqvi, M.
Khan, N.
DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A23 - A23
[22] New insulin glargine 300 U/ml: efficacy and safety of flexible vs fixed dosing intervals in people with type 2 diabetes mellitus
Jeandidier, N.
Riddle, M. C.
Bolli, G. B.
Home, P. D.
Bergenstal, R. M.
Ziemen, M.
Muehlen-Bartmer, I.
Wardecki, M.
Vinet, L.
Yki-Jarvinen, H.
DIABETOLOGIA, 2014, 57 : S393 - S394
[23] NEW INSULIN GLARGINE 300 U/ML: EFFICACY AND SAFETY OF FLEXIBLE VS FIXED DOSING INTERVALS IN PEOPLE WITH TYPE 2 DIABETES MELLITUS
Riddle, M. C.
Bolli, G. B.
Home, P. D.
Bergenstal, R.
Wardecki, M.
Vinet, L.
Yki-Jarvinen, H.
Jeandidier, N.
DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A103 - A104
[24] Efficacy and safety of insulin glargine 300 U/mL in people with T2D in China: the INITIATION study
Chen, L.
Wan, H.
Han, J.
Yang, C.
Shao, H.
Li, J.
Yan, W.
Zhang, M.
Li, M.
Han, Y.
Kang, L.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
[25] Evaluating the clinical effectiveness and safety of insulin glargine 300 U/mL in individuals with type 2 diabetes uncontrolled on basal insulin: A real-world evidence study from Saudi Arabia (EVOLUTION)
Al Malki, Faisal
El Damanhoury, Bandar
Othman, Abdallah
Alghamdi, Zain
AlQahtani, Majed
Madgy, Amr
Chouikrat, Zahir
DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 2869 - 2877
[26] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study
Gagik R. Galstyan
Amir Tirosh
Hernando Vargas-Uricoechea
Maria Aileen Mabunay
Mathieu Coudert
Mubarak Naqvi
Valerie Pilorget
Niaz Khan
Diabetes Therapy, 2022, 13 : 1187 - 1202
[27] Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta-analysis
Joshi, Shashank R.
Singh, Gursharan
Marwah, Ashwani
Mittra, Shivani
Suvarna, Viraj R.
Athalye, Sandeep N.
DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1589 - 1606
[28] The efficacy of switching from Insulin Glargine 100 U/mL (Gla-100) to Insulin Glargine 300 U/mL (Gla-300) in patients with type 2 diabetes mellitus
Yang, K. -H.
Tseng, C. -T.
Chen, L. -C.
Chen, P. -C.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 310 - 310
[29] Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) Compared with Other Basal Insulin Therapies in Patients with Type 2 Diabetes Mellitus (T2DM)-A Network Meta-analysis (NMA)
Wang, Hongwei
Zhang, Quanwu
Frois, Christian
Vlajnic, Aleksandra
Wu, Eric
Gerrits, Charles
Chou, Engels
DIABETES, 2015, 64 : A26 - A26
[30] Indirect treatment comparison (ITC) of efficacy and safety of insulin glargine 300 U/mL with once-daily-insulin premix in type 2 diabetes
Malik, R.
Ghosh, S.
Emral, R.
Malek, R.
Zeng, L.
Huang, Y.
Mabunay, M. A.
Landgraf, W.
Guyot, P.
Schenk, E.
Pushkarna, D.
Ritzel, R.
DIABETOLOGIA, 2022, 65 (SUPPL 1) : S332 - S332

← 1 2 3 4 5 →